Spero Therapeutics News - SPRO

Company Name	Stock Ticker Symbol	Market	Type
Spero Therapeutics Inc	SPRO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0592	4.14%	1.4892	12:35:35

Open Price	Low Price	High Price	Close Price	Prev Close
1.44	1.42	1.51		1.43

more quote information »

Recent News

Date	Time	Source	Heading
3/06/2024	08:05	GLOBE	Spero Therapeutics to Provide Business Update and Report..
2/28/2024	08:05	GLOBE	Spero Therapeutics Announces Clearance of IND for SPR206 to..
2/26/2024	08:05	GLOBE	Spero Therapeutics to Present at Cowen’s 44th Annual..
2/09/2024	16:05	EDGAR2	Form 8-K - Current report
2/05/2024	20:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	20:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	20:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	20:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	20:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	16:50	EDGAR2	Form 144 - Report of proposed sale of securities
1/31/2024	16:05	GLOBE	Spero Therapeutics Announces Inducement Grants Under Nasdaq..
1/08/2024	06:07	EDGAR2	Form 8-K - Current report
1/05/2024	08:11	EDGAR2	Form 8-K - Current report
1/05/2024	08:05	GLOBE	Spero Therapeutics Provides Corporate Update and 2024..
1/04/2024	16:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	08:13	EDGAR2	Form 8-K - Current report
1/02/2024	08:05	GLOBE	Spero Therapeutics Announces First Patient, First Visit for..
11/15/2023	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/15/2023	16:15	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/13/2023	16:50	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
11/13/2023	16:45	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
11/13/2023	16:13	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	GLOBE	Spero Therapeutics Announces Third Quarter 2023 Operating..
11/13/2023	16:02	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	06:45	IHMARKETNEWS	Monday’s Wall Street Highlights: Boeing, Novo Nordisk,..
11/06/2023	08:05	GLOBE	Spero Therapeutics to Provide Business Update and Report..
11/01/2023	16:05	GLOBE	Spero Therapeutics to Present at Upcoming November Investor..
11/01/2023	08:10	EDGAR2	Form 8-K - Current report
11/01/2023	08:05	GLOBE	Spero Therapeutics Appoints Esther Rajavelu as Chief..
10/31/2023	16:05	GLOBE	Spero Therapeutics Announces Inducement Grants Under Nasdaq..
10/16/2023	16:01	EDGAR2	Form 8-K/A - Current report: [Amend]
10/10/2023	17:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	17:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	08:28	EDGAR2	Form 8-K - Current report
9/29/2023	16:05	GLOBE	Spero Therapeutics Announces Inducement Grants Under Nasdaq..
9/20/2023	16:05	GLOBE	Spero Therapeutics to Present at Cantor’s Global Healthcare..
9/15/2023	17:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	08:05	GLOBE	Spero Therapeutics to Present at H.C. Wainwright 25th Annual..
9/01/2023	16:11	EDGAR2	Form ARS - Annual Report to Security Holders
9/01/2023	16:08	EDGAR2	Form DEF 14A - Other definitive proxy statements
8/31/2023	16:05	GLOBE	Spero Therapeutics Announces Inducement Grants Under Nasdaq..
8/30/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	16:16	EDGAR2	Form 144 - Report of proposed sale of securities
8/22/2023	17:27	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/10/2023	16:25	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/10/2023	16:17	EDGAR2	Form 8-K - Current report
8/10/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:05	GLOBE	Spero Therapeutics Announces Second Quarter 2023 Operating..